OBJECTIVES: Right anterior minithoracotomy with central arterial cannulation is our preferred technique of minimally invasive aortic valve replacement (AVR). We compared perioperative outcomes with this technique to those via sternotomy.
INTRODUCTION
Aortic valve replacement (AVR) is generally performed through a full median sternotomy. Despite the relatively low morbidity and mortality associated with this approach, various 'minimally invasive' techniques have been developed with the rationale that they would have the potential for less pain, shorter hospital stays, faster return to work and potential cost savings [1, 2] .
The most common minimally invasive approaches are the partial upper sternotomy and the small right anterior thoracotomy [3] . Rao and Kumar reported the first AVR via right thoracotomy in 1993, whereas the technique utilizing a small anterior thoracotomy in the third intercostal space was described by Benetti in 1997 [4, 5] . Other less common approaches include a partial lower sternotomy, transverse sternotomy and parasternal sternotomy [3, 6] . Cannulation for cardiopulmonary bypass can be performed centrally or peripherally. Several techniques of aortic control are also described, each having its own set of advantages and disadvantages [2, 7, 8] .
The surgical community generally accepts minimally invasive aortic valve surgery, and referring physicians and patients not infrequently expect it to be offered as an alternative to traditional full sternotomy. This expectation is based largely on single-centre retrospective and small prospective trials comparing AVR via a standard sternotomy with the various minimally invasive approaches [3, 8] . Reported advantages of minimally invasive aortic valve surgery include decreased blood loss, decreased length of stay and decreased morbidity. Few studies have shown a decrease in mortality, and no adequately powered prospective randomized trials have been reported.
We began performing minimally invasive AVR in 1999, preferentially utilizing a small right anterior thoracotomy with central arterial and venous cannulation and direct aortic cross-clamping whenever possible. The purpose of the present study was to compare perioperative outcomes in patients undergoing standard sternotomy versus minimally invasive right anterior thoracotomy for AVR at our centre.
MATERIALS AND METHODS

Patient selection and data collection
This was a retrospective, observational, cohort study of prospectively collected data from consecutive patients undergoing isolated AVR via either sternotomy or minimally invasive right anterior thoracotomy between 1999 and 2013 at the Keck Medical Center of USC (formerly USC University Hospital). All minimally invasive aortic valve procedures in our institution have been performed via a right anterior thoracotomy. Data were entered in an institutional database. Approval for the prospective database and this retrospective study was obtained from the University of Southern California Health Science Center Institutional Review Board (HS-053031).
We included patients who underwent both mechanical and tissue aortic valve implantation. We did not exclude any patients on the basis of emergent versus elective timing or aortic valve pathology. Patients requiring reoperative heart surgery, concomitant procedures such as coronary artery bypass grafting, mitral or other valve surgery, replacement of the ascending aorta or atrial fibrillation (AF) ablation were excluded. Patients undergoing aortic valve repair were also excluded.
The final analysis included two groups of patients who received either a bioprosthetic or mechanical aortic valve via either a standard sternotomy (SAVR) or a minimally invasive right anterior thoracotomy (MIAVR). Analysis was by intention to treat.
The individual surgeon and patient made the decision of whether a sternotomy or right anterior thoracotomy approach was utilized. Some surgeons used the right anterior thoracotomy approach in virtually all patients, whereas others used a sternotomy approach in virtually all patients. No specific contraindications to right anterior thoracotomy were routinely applied.
Definitions of adverse events
In-hospital mortality was defined as any death occurring during the same hospital admission for surgery. Postoperative AF was defined by the documentation of new-onset AF during postoperative hospitalization. Effusion or pneumothorax requiring a chest tube was defined as the need to place a secondary chest tube (or percutaneous drain) due to retained intrathoracic effusion or air during the initial operative admission or within 30 days of discharge. Postoperative gastrointestinal (GI) bleed included any case of GI haemorrhage confirmed by endoscopy. Postoperative pacemaker was defined by the need for implantation of a permanent pacemaker system postoperatively, prior to discharge. Pneumonia was defined based on clinical findings of fever, elevated white blood count, radiographic findings consistent with the diagnosis and treatment with antibiotics. Reintubation was defined as the need for replacement of the endotracheal tube and institution of mechanical ventilation during the initial hospital admission. Reoperation was defined as the need for any surgical reintervention during the operative admission or within 30 days of initial hospital discharge. Postoperative stroke was diagnosed if evidence was found of a new neurological deficit with a morphological substrate confirmed by computed tomography or nuclear magnetic resonance imaging. Wound infection was defined as clinical signs (erythema, drainage, pain) and positive wound cultures. Transfusions were only documented for intraoperative administration of packed red blood cells (PRBC) or platelets. Indications for transfusion were identical for both groups.
Operative technique
In addition to diagnostic coronary angiogram and transthoracic echocardiogram, preoperative work-up included a plain upright posterior-anterior and lateral radiographic chest film. Chest computed tomography was obtained only if standard chest X-ray suggested anatomical abnormalities that would make performing AVR via right thoracotomy difficult. The operative approach was at the discretion of the operating surgeon. External defibrillator pads were placed on the back and left chest prior to draping.
The minimally invasive approach was through a small 5-to 6-cm right anterior thoracotomy through the second, third or fourth intercostal space. The level of entry was selected on the basis of the operating surgeon's assessment of preoperative imaging. The right internal mammary artery was ligated, and the rib divided at the costochondral junction. Cannulation of the aorta and right atrium with standard low-profile cannulas was performed preferentially. If central cannulation was not possible for anatomical reasons or excessive calcification, then peripheral femoral arterial and/or venous cannulation was performed with appropriately sized percutaneous cannulas. A left ventricular vent was inserted through the right superior pulmonary vein, and tunnelled through the chest wall. Antegrade cardioplegia was through an aortic root cannula or direct coronary ostial cannulation. Retrograde cardioplegia was administered via a balloon-inflatable coronary sinus catheter inserted percutaneously into the right internal jugular vein, and positioned with the assistance of transesophageal echocardiogram (TEE) and fluoroscopy. The aorta was cross-clamped using a flexible clamp with a retractable rigid shaft. A transverse aortotomy was then made, and the aortic valve excised and replaced. At the conclusion of the operation, the pericardium was left open. Two 32-French chest drains were placed in the mediastinal and pericardial spaces for postoperative drainage. Most recently, plating of the divided rib is performed utilizing a sternal plating system in all patients. Use of sub-pleural pain catheters was at the discretion of the surgeon.
In the SAVR group, conventional median sternotomy, ascending aorta and dual-stage right atrial appendage cannulation, and antegrade and retrograde cardioplegia were used. AVR was by conventional techniques in both groups, using pledgeted interrupted annular suture placement. Moderate hypothermia (32°C), cold blood cardioplegia and vacuum-assisted cardiopulmonary bypass ADULT CARDIAC with a membrane oxygenator and arterial filter were used in all cases. TEE was routinely used for verification of coronary sinus catheter position, deairing, cardiac function, evaluation of prosthetic valve function and to confirm the absence of periprosthetic leaks. Postoperative care was not protocolized, and did not differ between the two groups.
Statistical analysis
Initial univariate comparisons between groups (MIAVR versus SAVR) on demographic and clinical characteristics as well as clinical outcomes used t-tests or Mann-Whitney U-(non-normally distributed) and χ 2 tests (Fisher's exact or Pearson) for categorical outcomes. Continuous data are reported as mean ± standard deviation; categorical variables are reported as number and percentage.
To adjust for the host of measured and unmeasured factors that might relate to the surgical approach (MIAVR versus SAVR) as well as clinical outcomes, propensity scores were developed. Using logistic regression with the surgical approach as the dependent variable, predicted probabilities for receiving MIAVR were estimated for each subject using a defined set of independent variables. These included: age (as a continuous variable), male gender, white (versus non-white) race, body mass index (BMI, as a continuous variable), New York Heart Association (NYHA) class, diabetes, history of AF, chronic obstructive pulmonary disease (COPD), history of MI, history of CVA or transient ischaemic attack (TIA), preoperative ejection fraction and the presence of a bicuspid aortic valve. Each independent variable was assessed independently to estimate the probabilities of having a MIAVR for each patient studied. Any missing values on independent variables were imputed using a random draw from distribution of the missing variable specific to each surgical group. For each subject, the model parameter estimates (logistic regression coefficients) were used to estimate their probability of having had MIAVR (versus SAVR) based on the subject-specific values of the demographic and clinical characteristics used in the predictive model; these predicted probabilities of MIAVR were used as propensity scores.
Propensity scores were categorized into quintiles, yielding a 5-level categorical variable. To evaluate the utility of the propensity scores, the demographic and clinical characteristics were compared between surgery groups with and without adjustment for the categorical propensity score. The distribution of the categorical propensity score was also compared between the surgery groups using a χ 2 test. The clinical outcomes were then compared between surgical groups using unadjusted as well as stratified analyses, using the categorical propensity score as the stratification variable. The association of surgery group with dichotomous outcomes [ postoperative stroke, mortality, wound infection, pacemaker placement, pneumonia, effusion/pneumothorax requiring chest tube placement, use of perioperative packed RBC (yes/no), use of perioperative platelets (yes/no)] used stratified logistic regression; results are reported as propensity-adjusted odds ratios, with 95% confidence intervals (CIs). 
RESULTS
Patient characteristics and operative data
A total of 492 patients were identified who underwent isolated AVR during the study period. A minimally invasive right anterior thoracotomy was performed in 294 patients (MIAVR group), while 198 had a standard median sternotomy (SAVR group).
Preoperative characteristics are presented in Table 1 . There were no differences between groups in age, gender, white race, BMI, NYHA Class, diabetes, pre-existing AF, previous myocardial infarction, or previous stroke and/or TIA. MIAVR patients had a trend towards more COPD (11 vs 7%, P = 0.10), slightly higher ejection fractions (60 vs 57%, P = 0.03), and were more likely to have a bicuspid valve (35 vs 18%, P < 0.001).
Operative data are presented in Table 2 . In the MIAVR group, the operative approach was via the second intercostal space in 136 (46%), third intercostal space in 102 (35%) and fourth . There were no differences in mean valve size implanted, cardiopulmonary bypass times or aortic cross-clamp times. Intraoperative blood and platelet requirements were lower in the MIAVR group (1.9 ± 2.2 vs 1.2 ± 1.6 units, P < 0.001 for blood and 1.1 ± 1.4 vs 0.6 ± 1.0 units, P < 0.001 for platelets). Three conversions from right anterior thoracotomy to sternotomy were performed (1%). Two were for coronary injuries requiring coronary artery bypass grafting and the third was to repair a left atrial injury.
Unadjusted postoperative outcomes
Unadjusted postoperative outcomes are reported in Table 3 . MIAVR patients had approximately one less ICU and hospital day (P < 0.001 for both). Mortality was similar between the SAVR and MIAVR groups (2.5 vs 1%, P = 0.28). In the SAVR group, 3 patients died of fatal arrhythmias and 2 died of multisystem organ failure (secondary to liver failure/sepsis in one, and renal failure/endocarditis in the other). In the MIAVR group, all deaths were due to multisystem organ failure from surgical complications ( postoperative dissection, coronary obstruction and left ventricular outflow tract obstruction).
Adverse events occurred with equal frequency in both groups with 0.62 adverse events per patient in the SAVR group and 0.55 adverse events per patient in the MIAVR group. There were no differences between groups in terms of new-onset AF, effusions or pneumothorax requiring secondary chest tube placement, gastrointestinal bleeding, need for postoperative pacemakers, reintubation, perioperative reoperations or strokes. There was a strong trend towards more postoperative pneumonia in the SAVR group (7.6 vs 3.4%, P = 0.06). Postoperative wound infections were more common in those patients undergoing a sternotomy (6.6 vs 1%, P = 0.004). None of these infections represented cases of mediastinitis; only one in the standard AVR group required surgical reintervention. The remainder of the wound infections were treated conservatively with bedside drainage, wound care and antibiotics. In addition, the composite end-point of freedom from perioperative mortality and any defined adverse event was significantly more common in the MIAVR group (74 vs 83%, P = 0.031).
Propensity score-adjusted postoperative outcomes
In an attempt to create two comparable groups, propensity scores were developed. Due to the small sample size of the SAVR group compared with the MIAVR group, we decided to use propensity stratification because propensity matching would have reduced the study size, particularly the MIAVR group, significantly. Table 4 demonstrates that, after developing imputing for missing variables and developing propensity scores, the SAVR and MIAVR groups were similar in terms of preoperative characteristics. Note all P-values have increased towards 1.0 and none are statistically different.
Continuous and dichotomous outcomes adjusted with stratification on propensity score quintiles are given in Table 5 . After propensity score adjustment, mortality and strokes remained similar between both groups (P = 0.56 and 0.26, respectively). Wound infections continued to be more common in the sternotomy group (P = 0.005), while postoperative pneumonia became equal between groups (P = 0.20). When examined as both a dichotomous (yes/no) and continuous variable, both the use of intraoperative blood and intraoperative platelets remained less common in the MIAVR group. Likewise, ICU and hospital length of stay remained significantly shorter in the MIAVR group when compared with the SAVR group. The significance of the composite end-point of alive and adverse event-free was eliminated by propensity analysis. ADULT CARDIAC
DISCUSSION
Minimally invasive AVR continues to gain acceptance in the surgical community. Clear benefits of this approach over standard sternotomy have been difficult to prove as the vast majority of studies lack a comparative group. Our study used a propensity score model to compare perioperative outcomes of AVR with two surgical approaches: minimally invasive right anterior thoracotomy and conventional sternotomy. Principal findings after propensity score analysis are decreased intraoperative blood usage, decreased ICU and hospital length of stays and decreased wound infections in the MIAVR group. Perioperative mortality and stroke rates were similar between groups. These findings and their magnitude are similar to much of the published literature. In particular, decreases in ICU LOS and rates of PRBC/platelet transfusion, while statistically different, are marginal improvements at 0.4 days, 0.7 units and 0.5 units, respectively. Such small differences are unlikely to be significant in daily clinical practice but do enforce that AVR via right anterior thoracotomy is a valid alternative to standard sternotomy.
Since the introduction of minimally invasive AVR in 1996 by Cosgrove and Sabik utilizing a parasternal incision, over 50 comparative studies have been published [6, 8] . Numerous meta-analyses have been published in this field [3, [7] [8] [9] . Phan et al. recently published an excellent summary and meta-analyses of studies were reported through November 2013, in which they identified 50 comparative studies with a total of 12 786 patients [8] . These studies included all minimally invasive surgical and cannulation approaches. It was concluded that the level of evidence is low and the populations are quite heterogeneous; however, the principal finding was that when compared with a standard sternotomy approach, minimally invasive AVR is associated with reduced transfusion requirement, decreased intensive care unit and hospital stays, decreased incidence of postoperative renal failure and a mortality and stroke rate at least comparable with conventional AVR. The results of our study are consistent with these observations as we found similar mortality and stroke rates with a decreased ICU and hospital length of stay, and decreased blood product usage with propensity score analysis. Our dataset unfortunately did not permit analysis of the occurrence of postoperative renal dysfunction/failure.
One difficulty in interpreting the literature and proving benefit to minimally invasive AVR is the multitude of surgical approaches available. The most common approaches remain the ministernotomy and the mini right anterior thoracotomy. These are quite different techniques, and likely associated with their own unique advantages and disadvantages. We prefer the mini right anterior thoracotomy for a variety of reasons including cosmesis, ease of surgical exposure, ability to centrally cannulate and our perception that it is associated with largely favourable outcomes and patient satisfaction.
To better understand our results and place them in context with prior studies, we conducted a comprehensive review of the literature to identify comparative minimally invasive AVR trials that included a right anterior thoracotomy as a surgical approach. A total of 15 studies (including the present manuscript) were identified with 1276 patients. These studies are summarized in Table 6 . Interestingly, the number of minimally invasive right anterior thoracotomy reports is increasing. Between 1998 and the end of 2009, there were 34 trials reported with 29 of these via ministernotomy or parasternal incisions and only 5 reports of right anterior thoracotomy [8] . However, from 2010 to present, there have been 18 reports, of which 12 were by minimally invasive right anterior thoracotomy. The increased reporting of the minimally invasive right anterior thoracotomy approach makes an analysis of its risks and benefits compared with other minimally invasive approaches and standard sternotomy techniques all the more timely. Of the right anterior thoracotomy trials reported most include less than 100 patients undergoing minimally invasive AVR. Only 5 included 100 or more right anterior thoracotomy patients [10, 17, 20, 21, 23] . Our right anterior thoracotomy group of 294 patients is the largest series reported to date.
Study design is imperfect in all trials, including our own, as eight reports were case-control studies and six (including ours) involved some type of propensity score analysis. One randomized controlled trial has been conducted, and reported in India with 30 patients in each group. Unfortunately, this study did not comprehensively report adverse events including stroke or mortality rates. Few studies offer long-term follow-up. Despite these limitations, consistent findings in these comparative reports of patient undergoing minimally invasive right anterior thoracotomy AVR versus conventional sternotomy are decreased ICU and hospital postoperative length of stay, decreased blood usage and decreased time on the ventilator postoperatively. Absence of a difference in mortality or stroke rates is also a consistent finding. With the exception of decreased time on the ventilator (which we did not analyse), our results are consistent with this literature. A consistent disadvantage reported in the literature that was not observed in the present study is increased cardiopulmonary bypass times and aortic cross-clamp times. Stroke rates are comparable with sternotomy and range between 0 and 8%, conversions rates of 0-5% are common and mortality ranges between 0 and 5%. 
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One confounding variable in all of these studies is variations in cannulation strategy. Most studies report primarily femoral cannulation, which may or may not be associated with increased stroke rates [2, 24] . LaPietra et al. reported 23 postoperative strokes (1.53%) in 1501 patients undergoing minimally invasive valve surgery (aortic, mitral and tricuspid). Femoral arterial cannulation was used preferentially in this centre; however, 20% were centrally cannulated. There were 19 strokes in the femoral cannulation group (1.4%) and 4 strokes in the central cannulation group (2.9%). The authors concluded that minimally invasive valve surgery is associated with an acceptable stroke rate regardless of cannulation technique. This is in contrast to the study of Murzi et al. who reported a perhaps more robust study using propensity analysis of 1280 patients undergoing first time minimally invasive valve surgery. The preference in this study was for central cannulation (87%). After adjusting for the propensity score, femoral cannulation was associated with a higher incidence of stroke (5 vs 1%, P < 0.002). These authors conclude that the use or femoral cannulation is associated with a higher incidence of neurological complications and aortic dissections when compared with central cannulation. They recommend central cannulation whenever possible.
Analysing studies with regard to cannulation technique in the minimally invasive right anterior thoracotomy AVR population is difficult. Six studies, including our own, report preferential central cannulation [10, 17, 20, 22, 23] . Discerning benefits (or determents) to this cannulation strategy from these studies is difficult and speculative at best as all studies are small and stroke rates were compared with the comparative surgical approach group, sternotomy in most cases, not an alternative form of cannulation. Our belief is that central cannulation may be advantageous in decreasing neurological events in these patients; however, data supporting this are lacking as only 20 of our patients underwent femoral cannulation and a comparative analysis would be underpowered at best, and misleading at worse. That said, given that the frequency of clinical strokes after AVR is likely much higher than even that reported in the Society of Thoracic Surgeons database (17 vs 7% in the study by Messe et al.) and silent infarcts are found in stroke-free patients routinely (54%), efforts to decrease strokes after AVR are of paramount importance and are likely to be the subject of active clinical trials in the near future [25] .
One additional finding of our study deserves mention. The unadjusted significance of the composite end-point of alive and free of adverse events perioperatively is interesting. The fact that the significance of this outcome is lost with propensity analysis suggests that there are a group of 'sicker' patients in the sternotomy cohort who get complications and do poorer than the average MIAVR patient. This observation is important because it provides perhaps the first real suggestion that there may be some patients who are too sick for a MIAVR, or alternatively, more appropriate for a conventional sternotomy. The characteristics of that patient population remain to be elucidated.
There are numerous limitations to this study including its retrospective nature, single institution practice, lack of long-term follow-up, lack of long-term echocardiographic data and lack of quality of life or patient satisfaction data. As with most other studies comparing lesser invasive with traditional techniques, surgeon bias in choosing one technique over another could not be avoided. Use of propensity score-matching modulates bias, but remains only a surrogate for a properly conducted randomized trial.
In conclusion, minimally invasive AVR via a small right anterior thoracotomy is associated with mortality and stroke rates comparable with that of conventional sternotomy. In addition, this minimally invasive approach appears to result in a lower rate of intraoperative blood product usage, shorter length of stays and decreased wound infections. When one considers those patients alive and free of perioperative adverse events, there is a suggestion that the MIAVR patients may do better in the perioperative period; however, this is likely due to patient selection and an appropriately designed prospective multicentre randomized trial with appropriate powered end-points is warranted to elucidate this further.
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Dr M. Amrani (London, UK): I like your study very much. It is a very elegant and simple study that compared 198 patients who underwent isolated aortic valve replacement via conventional sternotomy and you compared those patients to 294 patients who received a minimally invasive approach via a minithoracotomy. There were 3 conversions from right thoracotomy to sternotomy, which is approximately a 1% conversion rate.
You concluded that minimally invasive aortic valve replacement via a minithoracotomy is associated with less intraoperative blood products, lower wound infection rates, and decreased hospital and ICU stay. As for the mortality, there was no statistically significant difference.
I have a few questions for you. In your manuscript you stated that among all the surgeons who participated in this study, some, and I quote, used almost exclusively minithoracotomy and others used almost exclusively full sternotomy. Therefore, the question I have for you is obvious. Do you think that the experience of the surgeon one way or another can influence or bias your results?
My second question relates to the paravalvular leak, which is still a criticism made by some on those techniques. Do you have any echo data that could shed light on the difference between one technique and another with regard to paravalvular leak?
Finally, notwithstanding your statistical data, which are convincing, if you look closely at your raw data, we can clearly see that the reduction in blood usage represents 0.1 bag of red cells. The reduction in ICU and hospital stay is reflected by 0.07 days, which is about 1.6 hours. Therefore, my question to you is, do you think these data are clinically significant to support your conclusions?
Dr Bowdish: I think you hit the nail on the head. Are these numbers clinically significant and is a half-unit of blood clinically significant? The blood data would say that if you got the blood, then it doesn't really matter whether you got the extra half-unit of blood. So to answer your question, it is probably not clinically relevant. If you could ask the question who got no blood and who got some blood, then there might be some clinical relevance. I actually looked at that and it did not come out.
Yes, there is definitely surgeon bias in this study. Dr Starnes does pretty much 100% of his cases through a right anterior thoracotomy. There are 6 others in the practice who are in the paper. I had to include everybody to get enough sternotomies to do the comparison. We could have done a singlesurgeon, single-centre study, but you wouldn't have been able to do any comparison. I think experience clearly matters, and I think most of the other previous presenters would agree that having a mentor who you can work with and learn how to do this correctly and safely is very, very important. It clearly has affected the results. On the other hand, I think the data is sound.
Your second question? Dr Amrani: The echo data. Dr Bowdish: There were no differences in paravalvular leaks, at least postoperatively. Dr Cleveland is actually one of our integrated fellows and he is actually looking at hopefully getting late echo data to look at things like that, and so hopefully maybe next year we will have 3-year or 5-year echo data to answer that question. I don't really have the answer to that at this point.
Dr T. Fischlein (Nuremberg, Germany): Very nice data. My first question, did you do any preoperative CT scanning to see how far away the aorta is? The second question is, since you have such good data with your minithoracotomy, is it now the technique of your choice? You had excellent clamping times. However, there is no difference delineated with regards to clamping time after full sternotomy and minithoracotomy. Is this now the technique of the future in your institution? Dr Bowdish: Yes. As others have presented, the right anterior thoracotomy for isolated AVR and even AVR tricuspid valve is definitely our preferred approach. Our workup is as I described in the manuscript. I know many people in the literature, and Professor Glauber, recommend a CT scan preoperatively. We do not routinely get a CT unless we are worried about the physical characteristics of the patient. We get a PA and lateral chest X-ray to look at the relationship of the aorta and the sternum in the anterior and posterior directions. I personally don't think it's wrong to get a CT, but we have not routinely done that, no.
Dr Fischlein: So did you never have the problem that suddenly the aortic valve is too far away to actually do a valve replacement?
Dr Bowdish: Agreed. Have we ever had that problem? We have definitely struggled to get there, I'll say that. I think if I was recommending to someone to learn how to do this, getting a CT scan is definitely not inappropriate. Dr Bowdish: Yes. That is actually kind of how this started, was asking the question, with preferential central arterial cannulation, can you demonstrate a decrease in strokes or neurologic outcomes. In the minimally invasive, there is literature both for it and against it to suggest that retrograde perfusion may be detrimental. I think we just don't have enough patients or there is no difference between the two. Our technique is fairly standard aortic cannulation. We get fairly good exposure and tend to get some sort of clamp on the aorta for control, and then we use an EOPA cannula to cannulate the aorta.
Dr Dillon: My question is coming from the standpoint of if you do a right anterior thoracotomy and you do central cannulation, perhaps the wound is a little bit larger than if you do peripheral cannulation. If you approach it through a ministernotomy, then it wouldn't make a difference.
Dr Bowdish: True. Dr S. Canovas (Murcia, Spain): I have a comment. Sometimes we call minimally invasive surgery any surgery which is not performed via a full sternotomy, and sometimes in minimally invasive surgery there are many different techniques. Sometimes they take a longer time. Sometimes they take a shorter time. My question is, how big is your incision, and do you have to spread any ribs, break any ribs?
Dr Bowdish: We routinely detach one of the costal cartilages. It has evolved over time. We used to just use a wire and now we actually use a plate to put the rib back, that is our approach. We divide the right internal mammary artery and divide the inferior costal cartilage and then reattach it. We have also gone to putting a piece of mesh over the chest wall to try to prevent lung herniation.
I actually completely agree with your comment about the term 'minimally invasive' and this is perhaps not the other authors' opinions on the paper, but I think it is potentially misleading to patients as to what it really is, because it's still heart surgery. It's the same operation; it's just a different way of getting there. So maybe terms like alternative access may be more appropriate, but it's just semantics at the end of the day.
Dr Canovas: How long is your incision? Dr Bowdish: Generally 5 cm, 6 cm. It's fairly small.
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